禁煙および依存症治療：世界市場分析

Abstract

SMOKING CESSATION IS AN increasingly important area of focus for pharmaceutical companies, healthcare entities and governments. There are 1.4 billion smokers in the world, and smoking is a known cause of heart disease, lung cancer, respiratory infections and many other diseases. This has created a large market for smoking cessation aids.

The market, which Zyban currently holds a tenuous lock on, is about to change, with a major new brand ready to shake up the current market share. At the same time, the high incidence of smoking and strong public-sector motivation to reduce smoking signals room for new entrants.

The market for treatments for alcohol and drug abuse, now dominated by Subutex and Campral, will also see growth and a robust line of new products.

Kalorama' s Smoking Cessation and Addiction Treatments: A World Market Analysis covers the market for pharmaceuticals that assist with smoking cessation and addiction treatment.

Using information gathered for Kalorama' s larger report on Psychotherapeutics: the World Market and interviews with psychotherapeutic industry insiders therein, this report takes a more detailed look at the combined market for both smoking cessation and alcohol/drug addiction treatments. The report includes:

• Round-up of current products available.
• Market share of major players and brands.
• Forecasted revenues to 2010.
• Forecasted Market Share with consideration of new players.
• Current revenues for 2005.
• World incidence data for Nicotine Addiction, Drug Addiction and Alcohol Abuse.
• Reviews of new products in the pipeline.
• Key trends driving pharmaceutical treatments for smoking cessation and drug addiction.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

• Market Analysis
• Competitive Analysis
• Scope and Methodology

CHAPTER TWO: OVERVIEW

• Nicotine Addiction
• Drug Dependence
• Issues, Trends and� Developments
  • Cost Effectiveness of Smoking Cessation
  • Therapeutic Benefits
  • Importance of Physician Intervention
  • Alternative Therapies
  • Cautious Optimism for Lower U.S. Smoking
  • Genetic Risk Factors for Smoking and Drug Addiction
  • Incentive Based Treatments for Drug Abuse
  • Reimbursement
• Description of Current Products
  • Smoking Cessation
    • Chantix/Champix
    • Zyban
    • Accomplia
    • Nicotrol
  • Alcohol and Opiate Dependence and Related
    • Subutex
    • Campral
    • Methodone
    • ReVia/Naltrex
    • Antabuse
    • Narcan
    • Vivitrol
    • Depade
  • Research and Development
    • Acomplia
    • Lofexidine
    • Naltrexone Depot
    • Lybrel
    • SSR591813
    • Cyt002-NicQb
    • NicVAX

CHAPTER THREE: MARKET DATA AND ANALYSIS

• Markets by Geographical Segments
• U.S. Market
• European Union Market
• Japan and ROW Market
• Market Data by Indication
• Competitive Analysis

CHAPTER FOUR: Company Profiles

• Barr Laboratories, Inc
• Bristol-Myers Squibb
• Cephalon, Inc
• Forest Laboratories, Inc
• GlaxoSmithKline PLC
• Pfizer, Inc
• Sanofi-Aventis

TABLE of EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

• Exhibit 1: Cost of Smoking, Drug Abuse and Alchohol Addiction Worldwide
• Exhibit 2: Smoking Cessation & Addiction Treatment Market
• Exhibit 3: World Market Smoking Cessation and Addiction Treatments Leading Suppliers Market Share, Estimated 2005

CHAPTER TWO: OVERVIEW

• Exhibit 4: Estimated World Prevalence of Conditions
• Exhibit 5: Economic Cost of Smoking-Related Illness
• Exhibit 6: Cost of Drug Addiction International and US
• Exhibit 7: Benefits of Smoking Cessation
• Exhibit 8: Recent Smoking Cessation and Addiction Treatment Approvals
• Exhibit 9: Research and Development: Smoking Cessation and Addiction Treatments

CHAPTER THREE: MARKET DATA AND ANALYSIS

• Exhibit 10: Smoking Cessation & Addiction Treatment: Worldwide Market
• Exhibit 11: World Smoking Cessation & Addiction Treatment Market
• Exhibit 12: World Market: Smoking Cessation and Addiction Treatment Market by Geographical Segment 2003-2010
• Exhibit 13: World Market Smoking Cessation and Addiction Treatment Market by Geographical Segment, 2003-2010�
• Exhibit 14: World Market: Smoking Cessation and Addiction Treatment Market by Geographical Segment - Percent Distribution, 2003-2010
• Exhibit 15: World Market: Smoking Cessation and Addiction Treatment Market by Geographical Segment and Percent Market Share, 2005
• Exhibit 16: World Market Smoking Cessation and Addiction Treatment Market by Geographical Segment and Percent Market Share, 2010
• Exhibit 17: Estimated Smoking Cessation and Addiction Treatment Sales by Indication, 2005
• Exhibit 18: Drug Sales by Indication, 2005
• Exhibit 19: World Market Smoking Cessation and Addiction Treatments Leading Suppliers Shares by Market Revenues Estimated 2005 and Projected 2010
• Exhibit 20: World Market Smoking Cessation and Addiction Treatments Leading Suppliers Market Share, Estimated 2005
• Exhibit 21: World Market Smoking Cessation and Addiction Treatments Leading Suppliers Market Share, Projected 2010
• Exhibit 22: World Market Smoking Cessation and Addiction Treatments Leading Suppliers Shares by Market Revenues Estimated 2005 and Projected 2010
• Exhibit 23: Smoking Cessation and Addiction Treatment Market Top Drugs by Estimated Sales and Percent of Market, 2005
• Exhibit 24: Smoking Cessation and Addiction Treatment Market Top Drugs by Estimated Sales and Percent of Market, 2010